Showing 1 - 8 results of 8 for search 'Jörg Täubel', query time: 0.04s Refine Results
  1. 1
    Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial.

    Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial. by Jörg Täubel, Georg Ferber, Sara Fernandes, Ulrike Lorch, Eva Santamaría, Iñaki Izquierdo

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Comparing the consistency of electrocardiogram interval measurements by resting ECG versus 12‐lead Holter

    Comparing the consistency of electrocardiogram interval measurements by resting ECG versus 12‐lead Holter by Boaz Mendzelevski, Christopher S Spencer, Anne Freier, Dorothée Camilleri, Claus Graff, Jörg Täubel

    Published 2021-09-01
    Get full text
    Article
  3. 3
    Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval--A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity.

    Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval--A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising... by Jörg Täubel, Georg Ferber, Ulrike Lorch, Duolao Wang, Mariano Sust, A John Camm

    Published 2015-01-01
    Get full text
    Article
  4. 4
    Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges

    Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges by Charles Mundy, James Bush, Joseph Cheriyan, Ulrike Lorch, Steffan Stringer, Jörg Taubel, Kirsty Wydenbach, Timothy C. Hardman

    Published 2023-11-01
    Get full text
    Article
  5. 5
    Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers

    Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers by Jörg Täubel, Ulrike Lorch, Christopher S. Spencer, Anne Freier, Dorothée Camilleri, Dilshat Djumanov, Georg Ferber, Line Marchand, Jean-Pierre Gotteland, Oliver Pohl

    Published 2021-03-01
    Get full text
    Article
  6. 6
    Results of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria

    Results of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria by Anna Gaya, Talha Munir, Alvaro Urbano‐Ispizua, Morag Griffin, Jorg Taubel, Jim Bush, Ishir Bhan, Anna Borodovsky, Yue Wang, Prajakta Badri, Pushkal Garg

    Published 2023-08-01
    Get full text
    Article
  7. 7
    The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges

    The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges by Shahzadgai Khan, Muna Albayaty, James Bush, Joseph Cheriyan, Anthea Cromie, Annelize Koch, Michael Hammond, Stuart Mair, Ulrike Lorch, Steffan Stringer, Jorg Taubel, Timothy C. Hardman

    Published 2020-11-01
    Get full text
    Article
  8. 8
    The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development

    The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development by Susan Reijntjes, Muna Albayaty, James Bush, Joseph Cheriyan, Anthea Cromie, Annelize Koch, Michael Hammond, Stuart Mair, Peter Scholes, Ulrike Lorch, Steffan Stringer, Jorg Taubel, Timothy C. Hardman

    Published 2018-11-01
    Get full text
    Article

Search Tools: